Nixon Peabody Trust’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-989
Closed -$239K 91
2021
Q3
$239K Hold
989
0.09% 67
2021
Q2
$235K Sell
989
-146
-13% -$33.3K 0.09% 66
2021
Q1
$248K Buy
+1,135
New +$228K 0.1% 66
2020
Q4
Sell
-1,950
Closed -$315K 71
2020
Q3
$315K Hold
1,950
0.15% 66
2020
Q2
$278K Hold
1,950
0.14% 68
2020
Q1
$211K Hold
1,950
0.13% 69
2019
Q4
$283K Hold
1,950
0.14% 66
2019
Q3
$282K Sell
1,950
-262
-12% -$38.2K 0.15% 64
2019
Q2
$329K Hold
2,212
0.19% 65
2019
Q1
$291K Sell
2,212
-116
-5% -$14.3K 0.19% 66
2018
Q4
$253K Hold
2,328
0.2% 67
2018
Q3
$347K Hold
2,328
0.24% 64
2018
Q2
$359K Sell
2,328
-134
-5% -$20.2K 0.28% 62
2018
Q1
$342K Sell
2,462
-81
-3% -$11.9K 0.31% 56
2017
Q4
$349K Sell
2,543
-35
-1% -$4.63K 0.3% 59
2017
Q3
$334K Hold
2,578
0.3% 61
2017
Q2
$341K Sell
2,578
-786
-23% -$96.3K 0.32% 60
2017
Q1
$415K Hold
3,364
0.39% 58
2016
Q4
$371K Sell
3,364
-87
-3% -$9.66K 0.36% 60
2016
Q3
$408K Sell
3,451
-157
-4% -$18.5K 0.4% 63
2016
Q2
$404K Sell
3,608
-2,497
-41% -$269K 0.35% 66
2016
Q1
$615K Sell
6,105
-181
-3% -$17.4K 0.55% 59
2015
Q4
$667K Buy
+6,286
New +$648K 0.61% 59

Other funds holding LH

Nixon Peabody Trust's LH Position: Q4 2021 in Review

Nixon Peabody Trust sold out of Labcorp (LH) in Q4 2021, closing a stake of 989 shares — an estimated $239K sold.

Nixon Peabody Trust first reported a position in LH in Q4 2015 and held it in 23 quarters. The position peaked at $667K in Q4 2015. 1,062 funds tracked by Wall St. Rank hold LH as of Q4 2021.

  • Nixon Peabody Trust reported no remaining Labcorp position as of Q4 2021 after selling out during the quarter.
  • Nixon Peabody Trust sold 989 Labcorp shares in Q4 2021, an estimated $239K.
  • Nixon Peabody Trust first reported a position in Labcorp in Q4 2015 and held it in 23 quarters.
  • Nixon Peabody Trust's Labcorp position peaked at $667K in Q4 2015.
  • 1,062 funds tracked by Wall St. Rank held Labcorp as of Q4 2021.

Based on Nixon Peabody Trust's 13F filing for Q4 2021, filed 8 Feb 2022.